Statistical analysis was applied according to published methods (La Colla et al., 2009), and data revealed that activation of Beclin-1 either genetically (Becn1F121A/F121A) or pharmacologically (TB-peptide) significantly reduced the overall sickness scores in response to pneumonia-induced sepsis (Figure 2B). The gene discussed is BECN1; the disease is susceptibility to pneumonia measurement.